Diagnostic Services

Featured Image

DNA Damage Response Deficiency (DDRD) in Breast Cancer is associated with a STING-dependent Innate Immune Response

This may provide a therapeutic rationale for immune-checkpoint targeted therapies in the context of DNA damage response deficiency in cancer.

Download Brochure
Featured Image

Illumina TruSight Oncology 500 ctDNA Liquid Biopsy Panel: Application within Almac Diagnostic Services Laboratory

In this webinar presentation, recorded with kind permission from Illumina at their recent Comprehensive Genomic Profiling (CGP) event, hear from Killian McSorley, Assay Validation and Development Manager at Almac Diagnostic Services.

Download Brochure

Make an Enquiry

If you are interested in our Diagnostic Services, then please contact us
Contact Us
This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies